In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
about
Keratoprosthesis: A Review of Recent Advances in the FieldNovel therapies for open-angle glaucomaDiffusion-Based Design of Multi-Layered Ophthalmic Lenses for Controlled Drug ReleaseClinicians' perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma.Boston keratoprosthesis - Clinical outcomes with wider geographic use and expanding indications - A systematic review.Recent developments in ocular drug delivery.A review on therapeutic contact lenses for ocular drug delivery.A Novel Peptide Hydrogel for an Antimicrobial Bandage Contact Lens.Evaluation of the Safety and Tolerability of Conjunctival Ring for Posterior Segment of the Eye.Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection.Development of ciprofloxacin-loaded contact lenses using fluorous chemistry.Contact lenses for ophthalmic drug delivery.Differences in time-dependent mechanical properties between extruded and molded hydrogels.Release of Moxifloxacin from Contact Lenses Using an In Vitro Eye Model: Impact of Artificial Tear Fluid Composition and Mechanical Rubbing.Getting Drugs Across Biological Barriers.Zero-Order Antibiotic Release from Multilayer Contact Lenses: Nonuniform Drug and Diffusivity Distributions Produce Constant-Rate Drug Delivery.Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate.How can nanoparticles be used to overcome the challenges of glaucoma treatment?
P2860
Q26746855-5FBEF5E2-30AD-40C6-A27D-4C1F42F04C12Q26851132-9733D42D-8735-47FA-9939-E57A6A740919Q28554937-411C4416-8230-41DF-A61C-CA051386132AQ38270686-CB1D0483-1851-43EB-88B9-F0DB97BCCD86Q38544024-A52CC97F-2939-4352-9A62-FA203313CF31Q38603354-7CD18956-89B4-4F23-AD95-56BBCABF6B39Q38715163-609AEA36-FB7C-4CE6-9DB6-1413AD794013Q38765895-453D689B-C957-4B18-A5FD-77ACC18A1109Q38867563-5BCD1FFA-EF7B-4A1F-8C2F-5585B40B6724Q39195751-294D517E-F565-4481-B340-B24522020925Q40336319-F5013A15-4511-4A2E-92B5-8A5ED95C6298Q41994984-109A7DB1-C810-4AA4-BF79-881BF77AD337Q42364921-75F636E0-FEC4-4016-B32C-39247B0CB4BEQ42369732-774DE7F0-32BA-4E4C-A59C-5FEF946F0DC8Q48331228-EF53EF94-1DBF-403A-B47F-A6D185EA0795Q50904783-4BA0DD12-D2B8-4D20-8822-3AA620638FDCQ51453416-6BCFC567-DAB0-4F4C-8E54-588414AA89BBQ53451278-AA7A829A-3DC6-4196-B0BB-65FD50120A95
P2860
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
@en
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
@nl
type
label
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
@en
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
@nl
prefLabel
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
@en
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month.
@nl
P2093
P2860
P1433
P1476
In vivo performance of a drug-eluting contact lens to treat glaucoma for a month
@en
P2093
Amy E Ross
Borja Salvador-Culla
Cristina F Stefanescu
Daniel R Mascoop
Daniel S Kohane
Eden M Ford
Fabiano Cade
Kate A Wymbs
Priscila Cortez
Sarah L Sprague
P2860
P304
P356
10.1016/J.BIOMATERIALS.2013.09.032
P577
2013-10-04T00:00:00Z